BIIB Financial Facts
Income before income tax expense: 1.37BTotal revenues: 2.96B
See Full Income Statement
Commitments and contingencies (Notes 2, 11, 16, 18 and 20): 0
Other long-term liabilities: 862.1M
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
| Next EPS Date | 7/22/21 *Est. | EPS Growth Rate | -41.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +9.1% | Revenue Growth Rate | -23.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/22/21 | Q121 | $5.34 | $5.04 | +$0.30 | $2.69B | $2.65B | = |  | | Details | |
2/3/21  |
Q420 | $4.58 | $4.87 | -$0.29 | $2.85M | $2.8M | = | | | Details | |
| 10/21/20 |  |
Q320 | $8.84 | $8.13 | +$0.71 | $3.38B | $3.35B | = | | | Details |
| 7/22/20 | |
Q220 | $10.26 | $8.04 | +$2.22 | $3.68B | $3.44B | = | | | Details |
| 4/22/20 | |
Q120 | $9.14 | $7.74 | +$1.40 | $3.53B | $3.41B | = | | | Details |
| 1/30/20 | |
Q419 | $8.34 | $8.00 | +$0.34 | $3.67B | $3.54B | = | | | Details |
| 10/22/19 | |
Q319 | $9.17 | $8.27 | +$0.90 | $3.6B | $3.54B |  |
| | Details |
| 7/23/19 | |
Q219 | $9.15 | $7.53 | +$1.62 | $3.6B | $3.48B | |
| | Details |
